Drug price review to raise unbearable tensions to drug industries.

Published: 2006-10-16 07:00:00

Updated: 2006-10-16 07:00:00

A stormy aftermath of the 2006 government's drug price review may batter the drug industry with unbearable tensions, viewing that unlike the past reviews this year it included big seller products and large volumes.

The Health Insurance Review Agency (HIRA) disclosed "2006 regular drug price review report" in public for a week from today (Oct. 12) to Oct. 19 for the total 4,900 drugs of 1,376...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.